
News|Articles|January 30, 2025
Rapid and Quantitative Screening of Nitrosamines in Drug Products Using Headspace-SIFT-MS
Author(s)Syft Technologies Inc
This study demonstrates that headspace-SIFT-MS meets United States Pharmacopeia (USP) criteria for six nitrosamines, achieving low limits of quantitation (0.06 ppm for NDMA and 0.03 ppm for NDEA) even in complex drug matrices. With high recovery rates and significant reductions in solvent usage, consumables, and operational complexity compared to traditional chromatographic methods, the Syft Tracer Pharm11 solution is an efficient screening tool for nitrosamines and volatile impurities.
Trending on LCGC International
1
ASMS 2026: Phantom Metabolites and the Hidden Chemistry of Electrospray Ionization
2
How AI and Machine Learning Are Reshaping Separations Science at HPLC 2026
3
ASMS 2026 Award Winners Highlight the Future of Mass Spectrometry
4
Best of the Week: Chromatography Methods, HPLC 2026 Previews, and More
5
